The Blueprint Patient-Specific Instrumentation system by Stryker Corporation includes hardware and software components designed to assist surgeons in planning and performing shoulder replacement surgeries, specifically reversed shoulder arthroplasty. It uses CT scans to generate patient-specific surgical guides and implants, improving the precision of implant placement and potentially leading to better surgical outcomes for patients with shoulder joint conditions.
Blueprint Patient Specific Instrumentation assists in the intraoperative positioning of glenoid components for total anatomic or reversed shoulder arthroplasty using patient-specific landmarks from preoperative CT scans. Blueprint software serves as a pre-surgical planner for shoulder replacement surgery, visualizing and measuring anatomical shoulder data for adult patients and enabling design of patient-specific instruments and implants. The Shoulder iD Primary Reversed Glenoid implant replaces the native glenoid for patients with functional deltoid muscle and serious shoulder conditions.
The system comprises Blueprint Glenoid Guides (hardware) designed from preoperative CT-based planning by Blueprint Planning Software. The software connects to an Online Management System and assists surgeons in planning shoulder arthroplasty by allowing implant positioning, simulation, and design of patient-specific implants. The Shoulder iD Primary Reversed Glenoid implant includes a baseplate, screws, and glenosphere for non-cemented fixation. Both hardware and software have similar technological features as predicate devices, with differences addressed by performance testing.
The patient-specific instrumentation was validated by dimensional and cadaveric tests demonstrating equivalence to predicate devices. Software verification and validation confirmed the operating principle is consistent with predicate software. The Shoulder iD implant underwent non-clinical loosening testing confirming substantial equivalence. No clinical studies were performed.
No predicate devices specified
Submission
5/24/2024
FDA Approval
10/10/2024
Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.
We respect your privacy. Unsubscribe at any time.